ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI Meeting Scheduled For Applicants Of RFA On Pediatric Consortium

February 27, 1998

NCI Director Says Research Budget Cuts Result in Untold “Missed Opportunities,” Provides List of Program Reductions.

March 9, 2007

Neural Stem Cells Track, Treat, Brain Tumors In Mice

November 29, 2002

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

ASCO Foundation Renamed

February 18, 2011

FASEB Seeks $27.3B For NIH, Increases For Research, Training, And Infrastructure.

February 1, 2002